NL164272B - PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION BASED ON PROSTAGLANDINE F & 012ALFA OR E & 012 ANALOGS, OBTAINED BY USE THEREOF, PREPARED PREPARATION, AND PROCESS FOR PREPARING THE PREPARATION OF PREPARATION. - Google Patents

PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION BASED ON PROSTAGLANDINE F & 012ALFA OR E & 012 ANALOGS, OBTAINED BY USE THEREOF, PREPARED PREPARATION, AND PROCESS FOR PREPARING THE PREPARATION OF PREPARATION.

Info

Publication number
NL164272B
NL164272B NL7206361.A NL7206361A NL164272B NL 164272 B NL164272 B NL 164272B NL 7206361 A NL7206361 A NL 7206361A NL 164272 B NL164272 B NL 164272B
Authority
NL
Netherlands
Prior art keywords
preparation
preparing
012alfa
prostaglandine
analogs
Prior art date
Application number
NL7206361.A
Other languages
Dutch (nl)
Other versions
NL164272C (en
NL7206361A (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3967272A external-priority patent/GB1348036A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NL7206361A publication Critical patent/NL7206361A/xx
Publication of NL164272B publication Critical patent/NL164272B/en
Application granted granted Critical
Publication of NL164272C publication Critical patent/NL164272C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5352—Phosphoranes containing the structure P=C-
NL7206361.A 1971-05-11 1972-05-10 PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION BASED ON PROSTAGLANDINE F & 012ALFA OR E & 012 ANALOGS, OBTAINED BY USE THEREOF, PREPARED PREPARATION, AND PROCESS FOR PREPARING THE PREPARATION OF PREPARATION. NL164272C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1413971 1971-05-11
GB3967272A GB1348036A (en) 1970-05-15 1972-01-05 Transistorized vertical deflection circuit

Publications (3)

Publication Number Publication Date
NL7206361A NL7206361A (en) 1972-11-14
NL164272B true NL164272B (en) 1980-07-15
NL164272C NL164272C (en) 1980-12-15

Family

ID=26235892

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7206361.A NL164272C (en) 1971-05-11 1972-05-10 PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION BASED ON PROSTAGLANDINE F & 012ALFA OR E & 012 ANALOGS, OBTAINED BY USE THEREOF, PREPARED PREPARATION, AND PROCESS FOR PREPARING THE PREPARATION OF PREPARATION.

Country Status (26)

Country Link
JP (1) JPS5611699B1 (en)
AR (4) AR194952A1 (en)
AT (4) AT333447B (en)
AU (1) AU462755B2 (en)
BE (1) BE783292A (en)
CA (1) CA1077033A (en)
CH (3) CH596165A5 (en)
CS (1) CS192456B2 (en)
DD (1) DD99155A5 (en)
DE (1) DE2223365C3 (en)
DK (1) DK134598B (en)
EG (1) EG10752A (en)
ES (1) ES402627A1 (en)
FI (1) FI63221C (en)
FR (1) FR2137712A1 (en)
HK (1) HK50176A (en)
HU (1) HU166717B (en)
IE (1) IE37602B1 (en)
IL (1) IL39376A (en)
KE (1) KE2634A (en)
NL (1) NL164272C (en)
NO (1) NO139521C (en)
SE (4) SE399705B (en)
SU (1) SU662007A3 (en)
YU (1) YU35876B (en)
ZM (1) ZM8172A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304907A (en) * 1972-05-10 1981-12-08 The Upjohn Company Bicyclo lactone intermediates for prostaglandin analogs
DD118856A5 (en) * 1972-11-08 1976-03-20
US3968144A (en) * 1973-05-21 1976-07-06 The Upjohn Company 5-Oxa-11-deoxy phenyl- and phenoxy-substituted prostalandin E1 analogs
US3966795A (en) * 1973-05-21 1976-06-29 The Upjohn Company 5-Oxa-11-deoxyphenyl- and phenoxy-substituted prostaglandin F1.sub.α analogs
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
US4191774A (en) * 1978-01-18 1980-03-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Novel 17-aza-PGF2α derivatives and pharmaceutical compositions containing the same
US4228296A (en) * 1979-01-24 1980-10-14 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
US4929740A (en) * 1984-10-09 1990-05-29 Syntex (U.S.A.) Inc. Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
CS264861B1 (en) * 1986-12-12 1989-09-12 Kral Josef Agent for cow natality increase
CS265947B1 (en) * 1987-06-16 1989-11-14 Kral Josef Means for farming animals' ovarian functions control
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
CS276003B6 (en) * 1988-09-28 1992-03-18 Spolana method of production of (+)-isomer of cloprostenol
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
NZ585517A (en) * 2007-11-09 2012-08-31 Allergan Inc 5-[3-(2-Alkyl-cyclopentyl)-propyl]thiophene-2-carboxylic acid derivatives as prostaglandin analogues, and pharmaceutical uses thereof

Also Published As

Publication number Publication date
ATA419172A (en) 1976-03-15
AR194952A1 (en) 1973-08-30
SE399705B (en) 1978-02-27
SE7504335L (en) 1975-04-15
ATA539173A (en) 1975-05-15
NO139521B (en) 1978-12-18
BE783292A (en) 1972-11-10
CH590223A5 (en) 1977-07-29
DD99155A5 (en) 1973-07-20
ES402627A1 (en) 1975-11-01
AT328105B (en) 1976-03-10
ATA539073A (en) 1975-05-15
AR200484A1 (en) 1974-11-15
HU166717B (en) 1975-05-28
FR2137712A1 (en) 1972-12-29
AT333447B (en) 1976-11-25
IL39376A0 (en) 1972-07-26
AR197100A1 (en) 1974-03-15
IE37602B1 (en) 1977-08-31
ZM8172A1 (en) 1973-01-22
DE2223365B2 (en) 1980-07-31
FI63221C (en) 1983-05-10
NL164272C (en) 1980-12-15
DE2223365C3 (en) 1981-06-04
IE37602L (en) 1972-11-11
KE2634A (en) 1976-06-11
AT328104B (en) 1976-03-10
AR197101A1 (en) 1974-03-15
FI63221B (en) 1983-01-31
AT328103B (en) 1976-03-10
FR2137712B1 (en) 1976-04-16
HK50176A (en) 1976-08-13
DE2223365A1 (en) 1972-12-07
CA1077033A (en) 1980-05-06
SU662007A3 (en) 1979-05-05
CH596166A5 (en) 1978-02-28
JPS5611699B1 (en) 1981-03-16
AU462755B2 (en) 1975-07-03
IL39376A (en) 1975-07-28
YU125072A (en) 1981-02-28
CH596165A5 (en) 1978-02-28
NL7206361A (en) 1972-11-14
DK134598B (en) 1976-12-06
AU4202472A (en) 1973-11-15
SE7504337L (en) 1975-04-15
ATA538973A (en) 1975-05-15
EG10752A (en) 1976-05-31
DK134598C (en) 1977-05-16
CS192456B2 (en) 1979-08-31
NO139521C (en) 1979-03-28
YU35876B (en) 1981-08-31
SE7504336L (en) 1975-04-15

Similar Documents

Publication Publication Date Title
NL149153B (en) PROCESS FOR THE PREPARATION OF 1,3-BUTADIENE AND METHACROLEIN.
NL164272C (en) PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION BASED ON PROSTAGLANDINE F & 012ALFA OR E & 012 ANALOGS, OBTAINED BY USE THEREOF, PREPARED PREPARATION, AND PROCESS FOR PREPARING THE PREPARATION OF PREPARATION.
NL170147C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, FORMED PREPARATION THEREOF AND HETEROCYCLIC DIAMINES FOR THIS
NL7514940A (en) PROCESS FOR THE PREPARATION OF AZOLYL-1 METHANS AND THEIR SALTS AND THEIR USE AS MEDICINAL PRODUCTS.
NL167151C (en) PROCESS FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH ANTI-PARASITARY ACTION ON THE BASIS OF HALOGEN CONTAINING THE 2,2'-METHYLENE DIFENOL DERIVATIVES, AND METHOD FOR PREPARING THESE MEDICINAL COMPOUNDS.
NL166939C (en) METHOD FOR PREPARING MEDICINAL PRODUCTS WITH FAVORABLE BLOOD INFLUENCE AND METHOD FOR PREPARING SUITABLE COMPOUNDS
FI49503C (en) Analogous process for the preparation of 1,2,3,4-tetrahydro-4-phenylisoquinoline derivatives.
NL156404B (en) PROCESS FOR THE PREPARATION OF CHROMAND DERIVATIVES.
NL159981B (en) PROCESS FOR THE PREPARATION OF OXABICYCLOAL BRACES.
NL148602B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION INCLUDING 5-PLACE SUBSTITUTED 1-ALKYL-2-NITRO-IMIDAZOLE DERIVATIVES, AND FORMED PREPARATION AND PROCEDURE FOR PREPARING THESE COMPOUNDS.
NL159101B (en) PROCESS FOR THE PREPARATION OF A PREPARATION WITH RESPIRATORY ANALEPTIC ACTION BASED ON A SUBSTITUTED PYRIMIDYLPIPERAZINE, THE PREPARATIONS FORMED, AND A PROCESS FOR PREPARING THE ACTIVE COMPOUNDS.
NL160250C (en) PROCESS FOR PREPARING PROSTAGLANDINS OF THE "ONE" SERIES.
NL175190C (en) PROCESS FOR THE PREPARATION OF FLUORANES.
NL170529C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION BASED ON A 3-ALKOXY-1-ARYLOXYPROPANOL-2 AND METHOD FOR PREPARING THE COMPOUNDS TO BE USED THEREOF
NL7501430A (en) PROCEDURE FOR PREPARING AMINODIHYDROINS, PROCEDURE FOR PREPARING IDENTS AS WELL AS FORMED MEDICINAL PRODUCTS.
NL176252C (en) PROCESS FOR THE PREPARATION OF 1,4-DIACETOXYBUTANE.
NL161150B (en) METHOD OF PREPARING A MEDICINAL PRODUCT, AS WELL AS OBTAINED PREPARED MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING A BENZOFURAN COMPOUND.
NL169314C (en) METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SOURCE CHODILATOR ACTIVITY OBTAINED FROM MEDICINAL PRODUCT OBTAINED BY THIS METHOD AND METHOD FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF
NL171888C (en) PROCESS FOR THE PREPARATION OF CYCLODODECATRIES- (1.5.9.).
NL154514B (en) METHOD OF PREPARING A LOCAL EFFECTIVE MEDICINAL PRODUCT FOR THE SKIN AND MUMINOUS BASED ON A STEROID COMPOUND, AS WELL AS FORMED MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING THE ACTIVE COMPOUNDS.
NL181358C (en) PROCESS FOR THE PREPARATION OF 3,6-DICHLOROPICOLINIC ACID.
NL171163C (en) PROCESS FOR THE PREPARATION OF POLYIMIDE RESINS, AS PART OR PREPARED PREPARATION CONTAINED THEREOF
NL157314B (en) METHOD FOR PREPARING A 3-OXO-13BETA-R-17ALFA-X, 17BETA-HYDROXY-GONA-4,9,11-TRIES, AND METHOD FOR PREPARING A MEDICINAL PRODUCT AND USED THEREFOR.
NL160258B (en) PROCESS FOR THE PREPARATION OF 2,3-DIHYDROBENZODIA ZEPINES.
NL7411179A (en) PROCESS FOR PREPARING NEW CHINA ZOLINS OR THE ACID ADDITIONAL SALTS THEREOF, AND THE PHARMACEUTICAL PREPARATIONS PREPARED.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent